{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:36:33Z","timestamp":1793921793193,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To detail the outcomes of an open midline extraperitoneal (midline EP) approach to post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic testicular cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analysed our prospectively maintained operative database from April 2020 to February 2023 for cases of midline EP approach to PC-RPLND, identifying a total of 11 patients across two hospitals in Sydney, Australia. Demographic and perioperative data was obtained from electronic medical records, including preoperative factors such as cancer staging and preoperative treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eleven patients were included in this study. The median age was 37 years with a median ASA grade of 3. There were a total of six left-sided and five right-sided cases. A modified template was used in eight cases, and a bilateral template was used in three. Tumour staging ranged from Stage IIA\u2013 IIIB, with a median maximal retroperitoneal tumour size post chemotherapy of 4.2\u00a0cm. Preoperative histology identified 4 cases of seminoma and 7 cases of nonseminomatous germ cell tumours (NSGCT). The median length of the procedure was 300\u00a0min, blood loss was 300mL, length of stay was 5 days, and post-operative days until bowel opening was 2 days. The median lymph node yield was 18, with active malignancy identified in five cases. There were four early complications and no late complications. 91% of the patients had preserved ejaculatory function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The open midline EP approach to PC-RPLND has demonstrated acceptable perioperative outcomes compared to other open surgical approaches, enabling surgeons to complete complex cases. Therefore, the midline EP approach should be considered when performing PC-RPLND.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01853-0","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T05:38:46Z","timestamp":1752471526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical experience and outcomes of post chemotherapy midline extraperitoneal approach to retroperitoneal lymph node dissection"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8862-4269","authenticated-orcid":false,"given":"Basil","family":"Razi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"37","key":"1853_CR1","doi-asserted-by":"publisher","first-page":"e12390","DOI":"10.1097\/MD.0000000000012390","volume":"97","author":"JS Park","year":"2018","unstructured":"Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Med (Bmore). 2018;97(37):e12390.","journal-title":"Med (Bmore)."},{"issue":"1","key":"1853_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"1853_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.urology.2012.07.006","volume":"80","author":"P Kim","year":"2012","unstructured":"Kim P, Syan-Bhanvadia S, Djaladat H, Faber K, Tadros NN, Nichols C, et al. Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor. Urology. 2012;80(4):941\u20135.","journal-title":"Urology."},{"issue":"4","key":"1853_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(SICI)1098-2388(199912)17:4<263::AID-SSU7>3.0.CO;2-6","volume":"17","author":"J Baniel","year":"1999","unstructured":"Baniel J, Sella A. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol. 1999;17(4):263\u20137.","journal-title":"Semin Surg Oncol."},{"issue":"7","key":"1853_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1464-410X.2009.08888.x","volume":"105","author":"SB Williams","year":"2010","unstructured":"Williams SB, McDermott DW, Winston D, Bahnson E, Berry AM, Steele GS, et al. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data. BJU Int. 2010;105(7):918\u201321.","journal-title":"BJU Int."},{"issue":"3","key":"1853_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0090-4295(75)90166-1","volume":"05","author":"AN Tessler","year":"1975","unstructured":"Tessler AN, Yuvienco F, Farcon E. Paramedian extraperitoneal incision for total nephroureterectomy. Urology. 1975;05(3):397\u20138.","journal-title":"Urology."},{"issue":"6","key":"1853_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0022-5347(17)62428-5","volume":"101","author":"AH Ulm","year":"1969","unstructured":"Ulm AH. Transabdominal extraperitoneal rectus-retracting incision for surgery of the kidney and ureter. J Urol. 1969;101(6):797\u2013800.","journal-title":"J Urol."},{"issue":"5","key":"1853_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.eururo.2017.02.024","volume":"72","author":"S Syan-Bhanvadia","year":"2017","unstructured":"Syan-Bhanvadia S, Bazargani ST, Clifford TG, Cai J, Miranda G, Daneshmand S. Midline extraperitoneal approach to retroperitoneal lymph node dissection in testicular cancer: minimizing surgical morbidity. Eur Urol. 2017;72(5):814\u201320.","journal-title":"Eur Urol."},{"issue":"1","key":"1853_CR9","first-page":"60","volume":"213","author":"M Alsyouf","year":"2025","unstructured":"Alsyouf M, Ghoreifi A, Ashrafi A, Ladi-Seyedian SS, Ahmadi H, Burg M, et al. Eleven-year experience with midline extraperitoneal retroperitoneal lymph node dissection for germ cell tumors. J Urol. 2025;213(1):60\u201370.","journal-title":"J Urol."},{"issue":"5","key":"1853_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.eururo.2019.05.031","volume":"76","author":"AC Calaway","year":"2019","unstructured":"Calaway AC, Einhorn LH, Masterson TA, Foster RS, Cary C. Adverse surgical outcomes associated with robotic retroperitoneal lymph node dissection among patients with testicular cancer. Eur Urol. 2019;76(5):607\u20139.","journal-title":"Eur Urol."},{"issue":"2","key":"1853_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.21037\/tau.2020.02.09","volume":"9","author":"S Ray","year":"2020","unstructured":"Ray S, Pierorazio PM, Allaf ME. Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: a review. Transl Androl Urol. 2020;9(2):949\u201358.","journal-title":"Transl Androl Urol."},{"issue":"1","key":"1853_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bju.15986","volume":"132","author":"H Garg","year":"2023","unstructured":"Garg H, Mansour AM, Psutka SP, Kim SP, Porter J, Gaspard CS, et al. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes. BJU Int. 2023;132(1):9\u201330.","journal-title":"BJU Int."},{"issue":"5","key":"1853_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.euo.2024.01.006","volume":"7","author":"J Chavarriaga","year":"2024","unstructured":"Chavarriaga J, Atenafu EG, Mousa A, Langleben C, Anson-Cartwright L, Jewett M, et al. Propensity-matched analysis of open versus robotic primary retroperitoneal lymph node dissection for clinical stage ii testicular cancer. Eur Urol Oncol. 2024;7(5):1034\u201341.","journal-title":"Eur Urol Oncol."},{"key":"1853_CR14","doi-asserted-by":"publisher","unstructured":"Ghoreifi A, Sheybaee Moghaddam F, Mitra AP, Khanna A, Singh A, Chavarriaga J, et al. Oncological outcomes following robotic postchemotherapy retroperitoneal lymph node dissection for testicular cancer: a worldwide multicenter study. Eur Urol Focus. 2024;S2405-4569(24):00241\u20134. https:\/\/doi.org\/10.1016\/j.euf.2024.11.001.","DOI":"10.1016\/j.euf.2024.11.001"},{"issue":"3","key":"1853_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/096721090100900307","volume":"9","author":"T Igari","year":"2001","unstructured":"Igari T, Hoshino S, Iwaya F, Satokawa H, Midorikawa H, Takase S, et al. Results of 256 consecutive abdominal aortic aneurysm repairs using extraperitoneal approach. Cardiovasc Surg. 2001;9(3):249\u201353.","journal-title":"Cardiovasc Surg."},{"issue":"1","key":"1853_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1078-5884(97)80227-4","volume":"14","author":"CR Quick","year":"1997","unstructured":"Quick CR, Chan CL, Sonoda LI, Hart AJ. Midline extraperitoneal approach for elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 1997;14(1):63\u20138.","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"1853_CR17","first-page":"87","volume":"53","author":"C Rob","year":"1963","unstructured":"Rob C. Extraperitoneal approach to the abdominal aorta. Surgery. 1963;53:87\u20139.","journal-title":"Surgery."},{"issue":"4","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2302\/kjm.2017-0014-OA","volume":"67","author":"Y Otsuki","year":"2018","unstructured":"Otsuki Y, Konn H, Takeda K, Koike M. Midline extraperitoneal approach for obturator hernia repair. Keio J Med. 2018;67(4):67\u201371.","journal-title":"Keio J Med."},{"issue":"1","key":"1853_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/000313481808400110","volume":"84","author":"O Aydin","year":"2018","unstructured":"Aydin O, Pehlivanli F, Karaca G, Aydin G, Ozler I, Daphan C. Suprapubic midline extraperitoneal approach for widespread retroperitoneal abscess originating from anorectal abscess. Am Surg. 2018;84(1):17\u20139.","journal-title":"Am Surg."},{"key":"1853_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijscr.2015.12.001","volume":"19","author":"K Okuda","year":"2016","unstructured":"Okuda K, Oshima Y, Saito K, Uesaka T, Terasaki Y, Kasai H, et al. Midline extraperitoneal approach for bilateral widespread retroperitoneal abscess originating from anorectal infection. Int J Surg Case Rep. 2016;19:4\u20137.","journal-title":"Int J Surg Case Rep."},{"key":"1853_CR21","doi-asserted-by":"publisher","first-page":"1128864","DOI":"10.3389\/fnut.2023.1128864","volume":"10","author":"K Wang","year":"2023","unstructured":"Wang K, Xiao J, Li L, Li X, Yang Y, Liu Z, et al. The application of a medium-chain fatty diet and enteral nutrition in post-operative chylous leakage: analysis of 63 patients. Front Nutr. 2023;10:1128864.","journal-title":"Front Nutr."},{"key":"1853_CR22","doi-asserted-by":"publisher","first-page":"40053","DOI":"10.57187\/smw.2023.40053","volume":"153","author":"M Notarfrancesco","year":"2023","unstructured":"Notarfrancesco M, Fankhauser CD, Lorch A, Ardizzone D, Helnwein S, Hoch D, et al. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review. Swiss Med Wkly. 2023;153:40053.","journal-title":"Swiss Med Wkly."},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2016.01.010","volume":"91","author":"LC Macleod","year":"2016","unstructured":"Macleod LC, Rajanahally S, Nayak JG, Parent BA, Ramos JD, Schade GR, et al. Characterizing the morbidity of postchemotherapy retroperitoneal lymph node dissection for testis cancer in a national cohort of privately insured patients. Urology. 2016;91:70\u20136.","journal-title":"Urology."},{"key":"1853_CR24","doi-asserted-by":"publisher","unstructured":"Qian Z, D\u2019Andrea VD, Xiao B, Kielhofner J, Yim K, Stone BV, et al. Contemporary perioperative outcomes of open retroperitoneal lymph node dissection for testicular cancer. JU Open Plus. 2024;2(3):e00013. https:\/\/doi.org\/10.1097\/JU9.0000000000000114.","DOI":"10.1097\/JU9.0000000000000114"},{"issue":"2","key":"1853_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajur.2021.05.004","volume":"9","author":"T Shishido","year":"2022","unstructured":"Shishido T, Okegawa T, Hayashi K, Masuda K, Taguchi S, Nakamura Y, et al. Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: a comparison of clinical and perioperative outcomes. Asian J Urol. 2022;9(2):119\u201324.","journal-title":"Asian J Urol."},{"issue":"5","key":"1853_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.urolonc.2008.10.026","volume":"28","author":"VS Subramanian","year":"2010","unstructured":"Subramanian VS, Nguyen CT, Stephenson AJ, Klein EA. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol. 2010;28(5):504\u20139.","journal-title":"Urol Oncol."},{"issue":"1\u20132","key":"1853_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/ans.18182","volume":"93","author":"CJ Parkin","year":"2023","unstructured":"Parkin CJ, Sharma A, Winter M. How to do an open midline extraperitoneal bilateral retroperitoneal lymph node dissection for non-seminomatous germ cell tumour. ANZ J Surg. 2023;93(1\u20132):337\u20138.","journal-title":"ANZ J Surg."},{"issue":"5","key":"1853_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.eururo.2019.07.016","volume":"76","author":"J Sheinfeld","year":"2019","unstructured":"Sheinfeld J, Feldman DR, DiNatale RG, Bosl GJ. Altering the natural history of surgical relapse in testicular cancer: suboptimal surgery and pneumoperitoneum. Eur Urol. 2019;76(5):612\u20134.","journal-title":"Eur Urol."}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01853-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01853-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01853-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:44:10Z","timestamp":1757231050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01853-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01853-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Northern Sydney Local Health District - Royal North Shore Hospital Safety and Quality Unit (24-2022). The study was performed in accordance with the Declaration of Helsinki. Informed and written consent was obtained from all patients involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all patients for the use of their clinical data, pictures and videos.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}